Dr. Jiaoti Huang earned his medical degree from Anhui Medical University in 1983 and a Master’s degree in Pharmacology from the Institute of Radiation Medicine in Beijing in 1986. He earned his PhD from New York University School of Medicine (1987-1990). He was a Leukemia Society of America Postdoctoral Fellow at NYU and Yale University. He did residency training in pathology at NYU School of Medicine and a fellowship in Oncologic Surgical Pathology at Memorial Sloan-Kettering Cancer Center. He became an assistant professor at the University of Rochester in July 2000 and rose to the rank of full professor in 2007. Dr. Huang moved to UCLA in 2008 and came to Duke University at the beginning of 2016. He is currently Professor and Chairman of Department of Pathology, as well as Professor of Pharmacology and Cancer Biology at Duke University. He is also a member of the Duke Cancer Institute.
Dr. Huang is an expert surgical pathologist and prostate cancer researcher. His clinical expertise is in the pathologic diagnosis of genitourinary tumors. His research laboratory investigates the molecular mechanisms, biomarkers, imaging and novel therapies for advanced prostate cancer. His research laboratory is a leader in studying neuroendocrine differentiation of prostate cancer and molecular pathogenesis of prostatic small cell neuroendocrine carcinoma. Dr. Huang has published 200 research papers, review articles and book chapters. His research has been supported by the National Institutes of Health, Department of Defense Prostate Cancer Research Program, American Cancer Society, Prostate Cancer Foundation, and Stand Up to Cancer.